» Articles » PMID: 21504333

Ability to Perform Daily Physical Activities in Individuals with Type 2 Diabetes and Moderate Obesity: a Preliminary Validation of the Impact of Weight on Activities of Daily Living Questionnaire

Overview
Date 2011 Apr 21
PMID 21504333
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aims of this study were (1) to demonstrate the reliability and validity of the Impact of Weight on Activities of Daily Living Questionnaire (IWADL), a measure of ability to perform daily physical activities, in individuals with type 2 diabetes who are moderately obese and (2) to characterize those individuals with low self-reported ability.

Methods: Data from a web-based survey of individuals with type 2 diabetes and body mass index (BMI) of 30-40 k/mg(2) were used to calculate Cronbach's α and demonstrate both IWADL factorial and construct validity. These data were entered into a multivariable multinomial logistic regression model with survey variables (demographics, health status, weight- and diabetes-related) as the independent variables and three IWADL scoring groups (Low, Medium, and High) as the dependent variables.

Results: Study participants were 349 individuals with type 2 diabetes (mean age = 59 years, 44% male, 91% white, mean BMI = 35 k/mg(2)). Factor analysis indicated a one-factor solution for a seven-item IWADL with Cronbach's α = 0.94. Significant (P < 0.05) relationships were identified between IWADL and variables previously shown to be related to level of physical activity. Ten variables remained independently (P < 0.05) related to IWADL scores, including age, gender, health status, current exercise, using exercise programs or hypnosis as a step to lose weight, and self-reported weight history.

Conclusions: The IWADL is a reliable and valid measure of the ability of individuals with type 2 diabetes and moderate obesity to perform daily physical activities. This ability may be an important patient-reported end point to include in clinical trials of antihyperglycemic medications that produce weight loss.

Citing Articles

Improved Glycaemic and Weight Management Are Associated with Better Quality of Life in People with Type 2 Diabetes Treated with Tirzepatide.

Boye K, Sapin H, Dong W, Williamson S, Lee C, Thieu V Diabetes Ther. 2023; 14(11):1867-1887.

PMID: 37668888 PMC: 10570229. DOI: 10.1007/s13300-023-01457-7.


Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review.

Terwee C, Elders P, Blom M, Beulens J, Rolandsson O, Rogge A Diabetologia. 2023; 66(8):1357-1377.

PMID: 37222772 PMC: 10317894. DOI: 10.1007/s00125-023-05926-3.


Content Validity of Patient-Reported Outcome Measures Developed for Assessing Health-Related Quality of Life in People with Type 2 Diabetes Mellitus: a Systematic Review.

Terwee C, Elders P, Langendoen-Gort M, Elsman E, Prinsen C, van der Heijden A Curr Diab Rep. 2022; 22(9):405-421.

PMID: 35819705 PMC: 9355936. DOI: 10.1007/s11892-022-01482-z.


Patient-reported outcome measures for assessing health-related quality of life in people with type 2 diabetes: A systematic review.

Langendoen-Gort M, Groeneveld L, Prinsen C, Beulens J, Elders P, Halperin I Rev Endocr Metab Disord. 2022; 23(5):931-977.

PMID: 35779199 PMC: 9515038. DOI: 10.1007/s11154-022-09734-9.


Systematic review on the measurement properties of diabetes-specific patient-reported outcome measures (PROMs) for measuring physical functioning in people with type 2 diabetes.

Elsman E, Mokkink L, Langendoen-Gort M, Rutters F, Beulens J, Elders P BMJ Open Diabetes Res Care. 2022; 10(3).

PMID: 35675952 PMC: 9185403. DOI: 10.1136/bmjdrc-2021-002729.